Yuri S. Skoblov

Yuri S. Skoblov

Auto-generated profile, based on publicly available information

Yuri S. Skoblov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2026 in Genetics in Medicine
Verified
Journal Article
Closed access
DGDaria Gorodilova
Daria Gorodilova
Tatiana MarkovaTatiana Markova
Tatiana Markova
VKVladimir Kenis
Vladimir Kenis
EMEvgenii Melchenko
Evgenii Melchenko
AFAlexandra Filatova
Alexandra Filatova
MSMikhail Yu Skoblov
Mikhail Yu Skoblov

11 April 2023 in Journal of Clinical Practice
Verified
Journal Article
Open access
PDF file
ESE. V. Smolyakova
E. V. Smolyakova
YSYuri S. Skoblov
Yuri S. Skoblov
NSNatalia A. Skoblova
Natalia A. Skoblova
ARAnna V. Rvacheva
Anna V. Rvacheva
OBOlga V. Bondarets
Olga V. Bondarets
KZKirill Zykov
Kirill Zykov
Background: Comorbid cardiovascular and bronchoobstructive diseases worsens disease course and prognosis and causes difficulties in therapy. Effectiveness 2-agonists (cornerstone of bronchoobstructive pathology treatment) depends on -adrenoreceptors state. Therefore, a detailed study of the functional state of beta-adrenoreceptors is necessary. Aim: to evaluate the relationship of changes in the characteristics of 1- and 2-adrenoreceptors, against the background of the use of 2-agonists in patients with cardiovascular and bronchoobstructive diseases with clinically significant parameters. Methods: In the pilot single-center prospective study during 2.5 years 45 patients (15 with cardiovascular and 30 with bronchoobstructive diseases) were included. Anamnestic data and complaints were collected and laboratory and instrumental studies were performed. Modified radioligand analysis on blood T-lymphocytes using radiolabeled Cyanopindolol and unlabeled selective ligands (ICI 118551, CGP 20712) before and after salbutamol and formoterol was performed and the binding activity of 1- and 2-adrenoreceptors was determined. Results: The correlation analysis between clinically significant parameters and changes in the specific binding index of 1- and 2-adrenoreceptors confirmed its clinical relevance. In test with beta-agonists in cardiovascular and bronchoobstructive diseases patients, an increase in the specific binding index of 1-adrenoreceptors is associated with clinical, laboratory and instrumental parameters of a favorable course of the disease, and an increase in the specific binding index of 2-adrenoreceptors is associated with negative. In the cardiovascular group without bronchoobstructive diseases with salbutamol an increase in the specific binding index of 1-adrenoreceptors was associated with parameters of unfavorable disease course, while an increase in the specific binding index of 2-adrenoreceptors did not have a clear associative relationship with clinical characteristics. Conclusions: The association of changes in the specific binding index of 1- and 2-adrenoreceptors in patients with cardiovascular and bronchoobstructive diseases with clinically significant parameters during acute tests with short- and long-acting 2-agonists was revealed, which in the future may provide an opportunity to identify patients with an unfavorable course of the disease.

17 February 2025 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Closed access
PDF file
AEAnna V. Eremenko
Anna V. Eremenko
ESE. V. Smolyakova
E. V. Smolyakova
YSYuri S. Skoblov
Yuri S. Skoblov
ARAnna V. Rvacheva
Anna V. Rvacheva
KZKirill Zykov
Kirill Zykov
Background. Reseaching of the properties of β-adrenergic receptors (β-AR) is an urgent area in both fundamental and applied medicine. One of the most exact ways to determine the characteristics of β-AR is the radioligand method using [125I]cyanopindolol. This method сan determine the binding activity of β-AR on human blood cells. It is especially important to study the receptor link under the influence of various external factors and drugs. Aims — to evaluate the binding activity of β2-AR on T-lymphocytes of peripheral blood cells using radioligand analysis in healthy volunteers and in professional athletes under the influence of cholinergics. Methods. Healthy volunteers and athletes were given methacholine inhalation. Blood sampling was carried out initially on a clean background and after the methacholine test. To level out the differences in the conditions of formulation and to bring the results to the same coordinate system, the evaluation of the characteristics of β-AR in the framework of the study was carried out according to the specific binding index (ISS) — value reflecting the proportion of specific binding of receptors from the total specific. Results. During the study, when dividing volunteers into smokers and non-smokers, a tendency to decrease binding activity was noted. As a result of the study, in the general group of volunteers was registerd a significant decrease in the binding activity of beta2 receptors under the influence of methacholine. In the group of athletes, no significant changes were kept. Conclusions. The reason for these results may be both intense training, which changes the number of receptors, and the presence or absence of eosinophilic inflammation. The smoking factor does not play a significant role.